Friday Mar 29, 2024
Friday Mar 29, 2024

Another COVID-19 vaccine enters final trials


Nepalnews
2021 May 27, 14:31, PARIS
The Biden administration on Wednesday, May 5, joined calls for more sharing of the technology behind COVID-19 vaccines to help speed the end of the pandemic, a shift that puts the U.S. alongside many in the developing world who want rich countries to do more to get doses to the needy. Photo: AP

Production of another potential vaccine against COVID-19 will begin within weeks, its developers Sanofi and GlaxoSmithKline said Thursday as they launched a large Phase III trial enrolling 35,000 adult volunteers in the United States, Asia, Africa and Latin America.

The study will test the effectiveness of vaccine candidate formulas against the virus that spread from Wuhan, China, and against a variant first seen in South Africa, the pharmaceutical firms said.

If the trial is successful, regulators could approve the vaccine for use in the last three months of the year, the companies said in a statement.

“Manufacturing will begin in the coming weeks to enable rapid access to the vaccine should it be approved,” they added.

Their statement also quoted Thomas Triomphe, who leads vaccine research and development at Sanofi Pasteur, as saying:

“We are encouraged to see first vaccinations starting to take place in such an important, pivotal Phase 3 study.”

Vaccine covid-19 Wuhan vaccine candidate
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

KMC-02, UttarDhoka,
Lazimpat, Nepal

Newsroom
+977–01–4445751 / 4445754

E-mail
[email protected] [email protected]

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal